4.5 Letter

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 95, Issue 2, Pages E27-E28

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2011.08.016

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available